Metraipolis › archive › dc_03728ea4a239

A novel and innovative cancer classification framework through a consecutive utilization of hybrid feature selection — Europe PMC PMID:38102551

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38102551
DOI
10.1186/s12859-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-10-08T06:22:37.136Z
SHA-256 of the archived text
71d28e0b9bbac59edfc5994ba784a0217a256c5b5e7d1622fee534436a29a750
Stable URL of this page
https://metraipolis.com/documento/dc_03728ea4a239

How to cite

A novel and innovative cancer classification framework through a consecutive utilization of hybrid feature selection — Europe PMC PMID:38102551 — Europe PMC (en), https://europepmc.org/article/MED/38102551 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_03728ea4a239 (Metraipolis archive dc_03728ea4a239, sha256 71d28e0b9bbac59edfc5994ba784a0217a256c5b5e7d1622fee534436a29a750)
BibTeX
@misc{dc03728ea4a239,
  title = {A novel and innovative cancer classification framework through a consecutive utilization of hybrid feature selection — Europe PMC PMID:38102551},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38102551},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_03728ea4a239; sha256 71d28e0b9bbac59edfc5994ba784a0217a256c5b5e7d1622fee534436a29a750},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38102551. Agents can read the archived copy with the MCP tool read_document.